Calithera Biosciences Receives $40,000,000 Series A Round

  • Feed Type
  • Date
    7/7/2010
  • Company Name
    Calithera Biosciences
  • Mailing Address
    Undisclosed San Francisco, CA 94100
  • Company Description
    The company is developing a new class of anticancer therapeutics based on activation of caspases.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Specific proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Morgenthaler Ventures
  • Venture Investor
    U.S. Venture Partners
  • Venture Investor
    Advanced Technology Ventures
  • Venture Investor
    Delphi Ventures
  • Venture Investor
    Undisclosed

Next Post

Related Topics

Related Posts

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.